Unusual Machines, Inc.
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
UMAC$12.59-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Condensed Statements of Changes in Stockholders’ Equity
Consolidated Condensed Statement of Changes in Stockholders’ Equity
Three Months Ended March 31, 2024
| Series B, Preferred Stock · Common Stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||||
|---|---|---|---|---|---|---|---|
| Shares | Value | Shares | Value | Capital | Deficit | Equity | |
| Balance, December 31, 2023 | 190 | $2 | 3,217,255 | $32,173 | $4,715,790 | $(3,333,046) | $1,414,919 |
| Issuance of common stock as settlement | – | – | 16,086 | 161 | 64,183 | – | 64,344 |
| Issuance of common shares, initial public offering, net of offering costs | – | – | 1,250,000 | 12,500 | 3,837,055 | – | 3,849,555 |
| Issuance of common shares, business combination | – | – | 4,250,000 | 42,500 | 16,957,500 | – | 17,000,000 |
| Conversion of preferred shares | (120) | (1) | 600,000 | 6,000 | (5,999) | – | – |
| Net loss | – | – | – | – | – | (1,106,001) | (1,106,001) |
| Balance, March 31, 2024 | 70 | $1 | 9,333,341 | $93,334 | $25,568,529 | $(4,439,047) | $21,222,817 |
Three Months Ended March 31, 2025
| Series A, Preferred Stock · Series B, Preferred Stock · Series C, Preferred Stock · Common Stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Value | Shares | Value | Shares | Value | Shares | Value | Capital | Deficit | Equity | |
| Balance, December 31, 2024 | – | $– | – | $– | – | $– | 15,122,018 | $151,221 | $50,580,235 | $(35,913,514) | $14,817,942 |
| Issuance of restricted common stock, equity incentive plan | – | – | – | – | – | – | 483,546 | 4,835 | (4,835) | – | – |
| Cash exercise of warrants | – | – | – | – | – | – | 1,224,606 | 12,246 | 2,424,720 | – | 2,436,966 |
| Stock compensation expense - vested stock | – | – | – | – | – | – | – | – | 1,883,433 | – | 1,883,433 |
| Stock option compensation expense | – | – | – | – | – | – | – | – | 22,940 | – | 22,940 |
| Net loss | – | – | – | – | – | – | – | – | – | (3,266,279) | (3,266,279) |
| Balance, March 31, 2025 | – | $– | – | $– | – | $– | 16,830,170 | $168,302 | $54,906,493 | $(39,179,793) | $15,895,002 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.